---
title: Heterogeneity in the gene regulatory landscape of leiomyosarcoma
date: '2023-07-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37492373/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230726180750&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Characterizing inter-tumor heterogeneity is crucial for selecting suitable
  cancer therapy, as the presence of diverse molecular subgroups of patients can be
  associated with disease outcome or response to treatment. While cancer subtypes
  are often characterized by differences in gene expression, the mechanisms driving
  these differences are generally unknown. We set out to model the regulatory mechanisms
  driving sarcoma heterogeneity based on patient-specific, genome-wide gene regulatory
  ...
disable_comments: true
---
Characterizing inter-tumor heterogeneity is crucial for selecting suitable cancer therapy, as the presence of diverse molecular subgroups of patients can be associated with disease outcome or response to treatment. While cancer subtypes are often characterized by differences in gene expression, the mechanisms driving these differences are generally unknown. We set out to model the regulatory mechanisms driving sarcoma heterogeneity based on patient-specific, genome-wide gene regulatory ...